Iranian Journal of Veterinary Science and Technology

Article 8, Volume 12, Issue 2 - Serial Number 23, December 1399, Pages 59-67   

Document Type: Research Articles

DOI: 10.22067/ijvst.2020.64256.0

Authors

ناهید مژگانی¹; مهدی بابائی^{* 2}; نفیسه شکیبامهر²; محمد محمدطاهری²; نادر مصوری²; آرام قائم پناه²; کیومرث سلیمانی بابادی²

¹آزمایشگاه رفرانس سل گاوی، مؤسسه تحقیقات واکسن و سرم سازی رازی، سازمان تحقیقات، آموزش و ترویج کشاورزی (تات)، کرج، ایران.

²آزمایشگاه رفرانس سل گاوی، مؤسسه تحقیقات واکسن و سرم سازی رازی، سازمان تحقیقات، آموزش و ترویج کشاورزی (تات)، تهران، ایران.

Keywords

مایکوباکتریوم توبرکلوزیس; ESAT-6/CFP10; آمونیوم سولفات; کروماتوگرافی; وسترن بلات

References

1.    Mattow J, Jungblut PR, Müller EC, Kaufmann SH. Identification of acidic, low molecular mass proteins of Mycobacterium tuberculosis strain H37Rv by matrix-assisted laser desorption/ionization and electrospray ionization mass spectrometry. Proteomics. 2001; 1:494-507.
2.    Elston JW, Thaker HK. Co-infection with human immunodeficiency virus and tuberculosis. Indian J Dermatol Venereolleprol. 2008; 74:194-199.
3.    Seibert FB, Glen JT. PPD-S was comprised of approximately 92.1% protein, 5.9% polysaccharides and 1.2% nucleic acid. Am Rev Tuberc. 1941; 44:9-24.
4.    Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, Rane S, et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science. 1999; 284:1520-1523.
5.    Huebner RE, Schein MF, Bass JB. The tuberculin skin test. Clin Infect Dis. 1993; 17:968-975.
6.    Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006; 10:1192-1204.
7.    Shingadia D, Novelli V. The tuberculin skin test: a hundred, not out? Arch Dis Child. 2008; 93:189-190.
8.    Coler RN, Skeiky YA, Ovendale PJ, Vedvick TS, Gervassi L, Guderian J, et al. Cloning of a Mycobacterium tuberculosis gene encoding a purifed protein derivative protein that elicits strong tuberculosis-specific delayed-type hypersensitivity. J Infect Dis. 2000; 182:224-233.
9.    Kumar GSS, Venugopal AK, Selvan LDN, Marimuthu A, Keerthikumar S, Pathare S, et al. Gene expression profiling of tuberculous meningitis co-infected with HIV. J Proteomics Bioinform. 2011; 5:235-244.
10.    Brodin P, Majlessi L, Marsollier L, De Jonge MI, Bottai D, Demangel C, et al. Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. Infect Immun. 2006; 74:88-98.
11.    Meher AK, Bal NC, Chary KV, Arora A. Mycobacterium tuberculosis H37Rv ESAT-6/CFP-10 complex formation confers thermodynamic and biochemical stability. FEBS J. 2006; 273:1445-1462.
12.    Alito A, McNair J, Girvin RM, Zumarraga M, Bigi F, Pollock JM, et al. Identification of Mycobacterium bovis antigens by analysis of bovine T-cell responses after infection with a virulent strain. Braz J Med Biol Res. 2003; 36 (11):1523-1531.
13.    Lewinsohn DM, Grotzke JE, Heinzel AS, Zhu L, Ovendale PJ, Johnson M, et al. Secreted proteins from Mycobacterium tuberculosis gain access to the cytosolic MHC class-1 antigen-processing pathway. J Immunol. 2006; 177(1):437-442.
14.    Sørensen AL, Nagai S, Houen, G, Andersen P, Andersen AB. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun. 1995; 63(5):1710-1717.
15.    Vordermeier HM, Whelan A, Cockle PJ, Farrant L, Palmer N, Hewinson RG. Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle. Clin Diagn Lab Immunol. 2001; 8:571-578.
16.    Babaie M, Ghaempanah A, Mehrabi Z, Mollaei A. Partial purification and characterization of antimicrobial effects from snake (Echis carinatus), scorpion (Mesosobuthus epues) and bee (Apis mellifera) venoms. Iran J Med Microbiol. 2020; 14(5):460-477.
17.    Babaie M, Zolfagharian H, Jamili S, Zolfaghari M. Biochemical, hematological effects and complications of Pseudosynanceia melanostigma envenoming. J Pharmacopuncture. 2019; 22(3):140-146.
18.    Chevallet M, Luche S, Rabilloud T. Silver staining of proteins in polyacrylamide gels. Nat Protoc. 2006; 1(4):1852-1858.
19.    Babaie M, Zolfagharian H, Salmanizadeh H, Mirakabadi AZ, Alizadeh H. Isolation and partial purification of anticoagulant fractions from the venom of the Iranian snake Echis carinatus. Acta Biochim Pol. 2013; 60(1):17-20.
20.    Franco J, Camarena J, Nogueira J, Blanquer R, Ruiz M, Marin J. Serological response )Western blot( to fractions of Mycobacterium tuberculosis sonicate antigen in tuberculosis patients and contacts. Int J Tuberc Lung Dis. 2001; 5(10):958-962.
21.    Weldingh K, Andersen P. ESAT-6/CFP10 Skin Test Predicts Disease in M. tuberculosis-Infected Guinea Pigs. PLoS One. 2008; 3(4):1-8.
22.    Mahmoudi S, Mamishi S, Ghazi M, Sadeghi RH, Pourakbari B. Cloning, expression and purification of Mycobacterium tuberculosis ESAT-6 and CFP-10 antigens. Iran J Microbiol. 2013; 5(4):374-378.
23.    Van Pinxteren LA, Ravn P, Agger EM, Pollock J, Andersen P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol. 2000; 7:155-160.
24.    Andersen P, Andersen AB, Sørensen AL, Nagai S. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol. 1995; 154(7):3359-3372.
25.    Long ER, Seibert FB. The chemical composition of the active principle of tuberculin. Am Rev Tubercc. 1926; 13:393-397.
26.    Seibert FB, Pedersen KO, Tiselius A. Molecular weight, electro chemical and biological properties of tuberculin protein and polysaccharide molecules. J Exp Med. 1938; 68:413-438.
27.    Landi S, Held HR. Physicochemical and biological studies on various preparations of tuberculin purified protein derivative. Appl Microbiol. 1965; 13(2):132-139.
28.    Orme IM, McMurray DN, Belisle JT. Tuberculosis vaccine development: recent progress. Trends Microbiol. 2001; 9:115-118.
29.    Behar SM, Dascher CC, Grusby MJ, Wang CR, Brenner MB. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med. 1999; 189:1973-1980.
30.    Thaveekarn W, Pakmanee N, Suntrarachun S, Khow O, Udomsantisuk N. ESAT-6 protein for specific Mycobacterium tuberculosis in guinea pigs skin test. Sch Acad J Biosci. 2013; 1(7):357-362.
31.    Wu X, Feng S, Duan H, Zhang L, Zhang J, Yang Y, et al. Use of recombinant CFP-10 protein for a skin test specific for Mycobacterium tuberculosis infection. Afr J Biotechnol. 2010; 9(42):810-7185.
32.    Wu X, Zhang L, Zhang J, Zhang C, Zhu L, Shi Y. Recombinant early secreted antigen target 6 protein as a skin test antigen for the specific detection of Mycobacterium tuberculosis infection. Clin Exp Immunol. 2008; 152(1):81-87.
33.    Tebianian M, Hoseini AZ, Ebrahimi SM, Memarnejadian A, Mokarram AR, Mahdavi M, et al. Cloning, expression, and immunogenicity of novel fusion protein of Mycobacterium tuberculosis based on ESAT-6 and truncated C-terminal fragment of HSP70. Biologicals. 2011; 39(3):143-148.  
34.    Arend SM, Ottenhoff THM, Andersen P, Dissel JTV. Uncommon presentation of tuberculosis: the potential value of a noveldiagnostic assay based on the Mycobacterium tuberculosis-specificantigens ESAT-6 and CPF-10. Int J Tuberc Lung Dis. 2001; 7:680-686.
35.    Renshaw PS, Lightbody KL, Veverka V, Muskett FW, Kelly G, Frenkiel TA, et al. Structure and function of the complex formed by the tuberculosis virulence factors CFP-10 and ESAT-6. EMBO J. 2005; 24: 2491–2498.